Literature DB >> 4028438

Enzymatic fluorometric method for the determination of D-arabinitol in serum by initial rate analysis.

K Soyama, E Ono.   

Abstract

We describe a new, simple, fluorometric assay for D-arabinitol in serum. The method is based on oxidation of D-arabinitol by D-arabinitol dehydrogenase (EC 1.1.1.11), with the concomitant reduction of NAD. The initial rate of NAD reduction, which is proportional to the D-arabinitol content of serum, can be measured with a recording spectrofluorometer. Sensitivity, specificity, recovery and reproducibility experiments gave satisfactory results. The proposed method is suitable for clinical use, and may be helpful in the diagnosis of invasive candidiasis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4028438     DOI: 10.1016/0009-8981(85)90328-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  14 in total

1.  A rapid, automated enzymatic fluorometric assay for determination of D-arabinitol in serum.

Authors:  S F Yeo; Y Zhang; D Schafer; S Campbell; B Wong
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Effects of gastrointestinal candidiasis, antibiotics, dietary arabinitol, and cortisone acetate on levels of the Candida metabolite D-arabinitol in rat serum and urine.

Authors:  B Wong; K L Brauer; J R Clemens; S Beggs
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

3.  D-arabinitol versus mannan antigen and candidal protein antigen as a serum marker for Candida pyelonephritis.

Authors:  S Tokunaga; M Ohkawa; M Takashima; C Seto; S Nakamura
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

Review 4.  Nonculture methods for diagnosis of disseminated candidiasis.

Authors:  E Reiss; C J Morrison
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

5.  Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis.

Authors:  M E Bougnoux; C Hill; D Moissenet; M Feuilhade de Chauvin; M Bonnay; I Vicens-Sprauel; F Pietri; M McNeil; L Kaufman; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

6.  Diagnostic value of determination of serum mannan concentrations in patients with candiduria.

Authors:  S Tokunaga; M Ohkawa; M Takashima
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-07       Impact factor: 3.267

7.  Trichosporon cutaneum fungemia in patients with acute myeloblastic leukemia and measurement of serum D-arabinitol, Candida antigen (CAND-TEC), and beta-D-glucan.

Authors:  S Morimoto; C Shimazaki; H Goto; Y Hirata; T Tasumi; N Yamagata; T Hirata; E Ashihara; T Inaba; N Fujita
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

8.  Diagnosis of invasive candidiasis in patients with and without signs of immune deficiency: a comparison of six detection methods in human serum.

Authors:  G J Platenkamp; A M Van Duin; J C Porsius; H J Schouten; P E Zondervan; M F Michel
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

Review 9.  Current status of nonculture methods for diagnosis of invasive fungal infections.

Authors:  Siew Fah Yeo; Brian Wong
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

10.  Increased D-arabinitol/creatinine ratio in sera of patients with Behçet's disease during an active phase.

Authors:  S Hayasaka; S Noda; T Setogawa
Journal:  Br J Ophthalmol       Date:  1993-01       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.